ENDOLOGIX, INC. (NASDAQ:ELGX) Files An 8-K Other EventsItem 8.01 Other Events.
Notwithstanding the ongoing and devastating impact of the Santa Rosa fires, Endologix, Inc.’s(the “Company”) Santa Rosa, California-based facility that manufactures and develops its Ovation® product line is safe and secure, and its operations have not been materially affected by the aforementioned. The Company resumed shipments from its Santa Rosa facility on Tuesday, October 10th, following a brief delay, and plans to resume manufacturing soon. Many of the Company’s Santa Rosa employees have been adversely impacted by the fire, but they remain committed to the continued development, manufacturing, and support of aortic devices for physicians and their patients.
About ENDOLOGIX, INC. (NASDAQ:ELGX)
Endologix, Inc. is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders. The Company’s products are intended for the treatment of abdominal aortic aneurysms (AAA). The AAA products are built on one of two platforms, including traditional minimally invasive endovascular repair (EVAR) or endovascular sealing (EVAS), its solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens. The EVAR products include the Endologix AFX Endovascular AAA System (AFX), the VELA Proximal Endograft (VELA) and the Endologix Powerlink with Intuitrak Delivery System (Intuitrak). The EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). Its EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). It offers accessories to facilitate the optimal delivery of its EVAR products, including compatible guidewires, snares, and catheter introducer sheaths.